Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAI versus TAI plus H101 for non-small cell lung cancer
ChiCTR-OPN-15006746Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2015
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics, Gene Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Oncorine in non-small cell lung cancer (NSCLC) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: FPS and overall survival. Started Jun 2015; status: recruiting.
02
Drugs
Oncorine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-OPN-15006746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15006746.